A61K49/0466 - CPC Classification Index

ClassID:

21469 ⎘

A61K49/0466 - CPC Classification

Classification description:

Preparations for testing; X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent; Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound; Dispersions, colloids, emulsions or suspensions Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Recent Application in this class:

20210186875

2021-06-24

MULTI-COMPONENT NANOCHAINS

20190307687

2019-10-10

Multi-component nanochains

20180140672

2018-05-24

ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS

20170216206

2017-08-03

Multi-component nanochains

20170000910

2017-01-05

Polyphosphazene delivery system for inorganic nanocrystals

20160228580

2016-08-11

Mixed micelles

20160095944

2016-04-07

Multimodal CT/optical agents

20150313962

2015-11-05

Administration of growth factors for the treatment of CNS disorders

20150125393

2015-05-07

Liposome and method for producing liposome

#10

20140248339

2014-09-04

Multi-component nanochains

#11

20140219924

2014-08-07

Medical tissue-marker and manufacturing method for the same

#12

20140193330

2014-07-10

Compositions and methods for multimodal imaging

#13

20140017297

2014-01-16

Administration of growth factors for the treatment of CNS disorders

#14

20130189187

2013-07-25

Nano-scale contrast agents and methods of use

#15

20120258044

2012-10-11

Lipid-based nanoparticles

#16

20120225017

2012-09-06

Mixed micelles

#17

20120009245

2012-01-12

Administration of growth factors for the treatment of CNS disorders

#18

20120003159

2012-01-05

COMPOSITIONS AND METHODS FOR ENHANCING CONTRAST IN IMAGING

#19

20110200530

2011-08-18

Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same

#20

20110045060

2011-02-24

KIT FOR DETECTING CANCER CELLS METASTASIZING INTO SENTINEL LYMPH NODE

#21

20100215582

2010-08-26

LIPOSOME AND METHOD FOR PRODUCING LIPOSOME

#22

20100202974

2010-08-12

Nano-scale contrast agents and methods of use

#23

20100135913

2010-06-03

Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics

#24

20090311191

2009-12-17

IMAGING OF ATHEROSCLEROTIC PLAQUES USING LIPOSOMAL IMAGING AGENTS

#25

20090280055

2009-11-12

Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods

#26

20090263326

2009-10-22

Nano-scale contrast agents and methods of use

#27

20090208409

2009-08-20

ENCAPSULATED NANOPARTICLES FOR COMPUTED TOMOGRAPHY IMAGING

#28

20090185976

2009-07-23

METHOD FOR INTRODUCING A CHEMICAL AGENT INTO THE SYSTEMIC CIRCULATION

#29

20080206151

2008-08-28

Liposomes

#30

20080206131

2008-08-28

Compositions and method for multimodal imaging

#31

20080131369

2008-06-05

Compositions And Methods For Enhancing Contrast In Imaging

#32

20070254842

2007-11-01

Administration of growth factors for the treatment of CNS disorders

#33

20070212303

2007-09-13

Compositions and methods for enhancing contrast in imaging

#34

20070134154

2007-06-14

Tumor-targeted nanodelivery systems to improve early MRI detection of cancer

#35

20060062726

2006-03-23

Glycerol ester derivative

#36

20060018828

2006-01-26

Liposome-containing radiographic contrast medium and preparation method thereof

#37

20050238584

2005-10-27

Compositions and methods for enhancing contrast in imaging

#38

20050195943

2005-09-08

Method of forming subtraction images

#39

20050113675

2005-05-26

Ionic and non-ionic radiograhic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics

#40

20050002864

2005-01-06

1,3-glyceride compound having two iodophenyl groups